Roberto Tanenbaum

Application Specialist at Signant Health - Blue Bell, Pennsylvania, US

Roberto Tanenbaum's Colleagues at Signant Health
Grant Stopperich

Manager, Business Development

Contact Grant Stopperich

Lauren Hill

Project Support Associate

Contact Lauren Hill

Naseth Keo

Fulfillment Specialist

Contact Naseth Keo

Alexis Kelly

Implementation Project Manager

Contact Alexis Kelly

Valerie Conicelli

Implementation Project Manager

Contact Valerie Conicelli

View All Roberto Tanenbaum's Colleagues
Roberto Tanenbaum's Contact Details
HQ
267-422-1700
Location
Plymouth Meeting, Pennsylvania, United States
Company
Signant Health
Roberto Tanenbaum's Company Details
Signant Health logo, Signant Health contact details

Signant Health

Blue Bell, Pennsylvania, US • 2120 Employees
Major Drugs

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more atwww.signanthealth.com.

Electronic Data Capture Clinical Trial Patient Engagement
Details about Signant Health
Frequently Asked Questions about Roberto Tanenbaum
Roberto Tanenbaum currently works for Signant Health.
Roberto Tanenbaum's role at Signant Health is Application Specialist.
Roberto Tanenbaum's email address is ***@signanthealth.com. To view Roberto Tanenbaum's full email address, please signup to ConnectPlex.
Roberto Tanenbaum works in the Major Drugs industry.
Roberto Tanenbaum's colleagues at Signant Health are Grant Stopperich, Lauren Hill, Naseth Keo, Alexis Kelly, Charles Maguire, Valerie Conicelli, Brandy Morneau and others.
Roberto Tanenbaum's phone number is 267-422-1700
See more information about Roberto Tanenbaum